Books on the topic 'Drug selection'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 books for your research on the topic 'Drug selection.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse books on a wide variety of disciplines and organise your bibliography correctly.
Scotti, Marcus T., and Carolina L. Bellera, eds. Drug Target Selection and Validation. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-95895-4.
Full textTrottet, Lionel, and Howard Maibach, MD. Dermal Drug Selection and Development. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-59504-7.
Full textMeeting, World Health Organization Expert Committee on the Selection and Use of Essential Medicines. The selection and use of essential medicines. World Health Organization, 2003.
Find full textPatrick, Augustijns, and Brewster Marcus, eds. Solvent systems and their selection in pharmaceutics and biopharmaceutics. Springer, 2007.
Find full textL, Steiner Robert, and United States. Federal Trade Commission. Bureau of Economics, eds. Generic substitution and prescription drug prices: Economic effects of state drug product selection laws. Bureau of Economics, Federal Trade Commission, 1985.
Find full textMasson, Alison. Generic substitution and prescription drug prices: Economic effects of state drug product selection laws. Bureau of Economics, Federal Trade Commission, 1985.
Find full textVenitz, J., and W. Sittner, eds. Appropriate Dose Selection — How to Optimize Clinical Drug Development. Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-49529-1.
Full textUnited States. Office of Educational Research and Improvement., ed. Drug prevention curricula: A guide to selection and implementation. Office of Educational Research and Improvement, U.S. Dept. of Education, 1988.
Find full textSimons, David R. Hypertension: A physician's guide to drug selection and use. Keyed Reviews Publications, 1986.
Find full textParmeter, John E. Guide for the selection of drug detectors for law enforcement applications. U.S. Dept. of Justice, Office of Justice Programs, National Institute of Justice, 2000.
Find full text1957-, Gibson Mark, ed. Pharmaceutical preformulation and formulation: A practical guide from candidate drug selection to commercial dosage form. Interpharm Press, 2001.
Find full textWorld Health Organization (WHO). The Selection and Use of Essential Medicines: Report of the WHO Expert Committee 2007. World Health Organization, 2008.
Find full textS, Handen Jeffrey, ed. Industrialization of drug discovery: From target selection through lead optimization. Dekker/CRC Press, 2005.
Find full textW, Murray Dale, Hannum D. W, National Institute of Standards and Technology (U.S.). Office of Law Enforcement Standards., National Institute of Justice (U.S.). Office of Science and Technology., and Law Enforcement and Corrections Standards and Testing Program (U.S.), eds. Guide for the selection of drug detectors for law enforcement applications. U.S. Dept. of Justice, Office of Justice Programs, National Institute of Justice, 2000.
Find full textD, Quick Jonathan, Management Sciences for Health (Firm), and Action Programme on Essential Drugs and Vaccines (World Health Organization), eds. Managing drug supply: The selection, procurement, distribution, and use of pharmaceuticals. 2nd ed. Kumarian Press, 1997.
Find full textPauly, Mark V. Adverse selection and the challenges to stand-alone prescription drug insurance. National Bureau of Economic Research, 2003.
Find full textAhn, Hyewon. Patentability of chemical selection inventions: The Olanzapine and Escitalopram decisions. Nomos, 2011.
Find full textMellors, John W. Selection and characterization of drug-resistant variants of human immunodeficiency virus (AIDS): [final report]. [U.S. Army Medical Research and Materiel Command], 1995.
Find full textDerek, Chadwick, and Goode Jamie, eds. Antibiotic resistance: Origins, evolution, selection, and spread. Wiley, 1997.
Find full textUnited States. Department of Justice. Audit Division. The Drug Enforcement Administration's use of intelligence analysts. U.S. Dept. of Justice, Office of the Inspector General, Audit Division, 2008.
Find full textWHO Expert Committee on the Selection and Use of Essential Medicines. The selection and use of essential medicines. World Health Organization, 2004.
Find full textNebraska. 1989 state of Nebraska statutes, rules, and regulations relating to, pharmacy ; Nebraska Drug Product Selection Act. Dept. of Health, Bureau of Examining Boards, 1989.
Find full textLefevre, Ethan C. Food labelling: The FDA's role in the selection of healthy foods. Nova Science Publishers, 2009.
Find full textMarc, Fishman, and American Society of Addiction Medicine., eds. ASAM patient placement criteria: Supplement on pharmacotherapies for alcohol use disorders. Lippincott William & Wilkins, 2010.
Find full textFishman, Marc. ASAM patient placement criteria: Supplement on pharmacotherapies for alcohol use disorders. Edited by American Society of Addiction Medicine. Wolters Kluwer Health/Lippincott Williams & Wilkins, 2010.
Find full text1937-, Azar Isaac, ed. Muscle relaxants: Side effects and a rational approach to selection. Dekker, 1987.
Find full textL, Gall Timothy, and Lucas Daniel M, eds. Statistics on alcohol, drug & tobacco use: A selection of statistical charts, graphs, and tables about alcohol, drug, and tobacco use from a variety of published sources with explanatory comments. Gale Research, 1996.
Find full textCasey, Verna. The screening of employees: A selected bibliography. Vance Bibliographies, 1988.
Find full textUnited States. Congress. Senate. Committee on the Judiciary. Mr. Robert Martinez to be director of National Drug Control Policy: Report together with supplemental, additional and minority views (to accompany the nomination of Mr. Bob Martinez to be director of National Drug Control Policy). U.S. G.P.O., 1991.
Find full textOffice, General Accounting. Drug war: Drug Enforcement Administration staffing and reporting in Southeast Asia : report to the Chairman and Ranking Minority Member, Committee on Government Operations, House of Representatives. U.S. General Accounting Office, 1992.
Find full textUnited States. Congress. Senate. Committee on the Judiciary. Nomination of Robert Martinez to be director of the Office of National Drug Control Policy (drug czar): Hearings before the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session ... February 26 and 27, 1991. U.S. G.P.O., 1992.
Find full textOffice, General Accounting. Drug war: Observations on counternarcotics aid to Colombia : report to Congressional requesters. U.S. General Accounting Office, 1991.
Find full textUnited States. Congress. Senate. Committee on the Judiciary. Confirmation hearing on the nomination of Asa Hutchinson to be Administrator of the Drug Enforcement Administration: Hearing before the Committee on the Judiciary, United States Senate, One Hundred Seventh Congress, first session, July 17, 2001. U.S. G.P.O., 2002.
Find full textWilliamson, Elizabeth M. Selection, preparation, and pharmacological evaluation of plant material. J. Wiley, 1996.
Find full textOffice, General Accounting. The drug war: U.S. programs in Peru face serious obstacles : report to Congressional requesters. U.S. General Accounting Office, 1991.
Find full textOffice, General Accounting. The drug war: U.S. programs in Peru face serious obstacles : report to congressional requesters. The Office, 1991.
Find full textJudiciary, United States Congress Senate Committee on the. Dr. William J. Bennett to be Director of National Drug Control Policy: Report together with additional and minority views (to accompany the nomination ...). U.S. G.P.O., 1989.
Find full textUnited States. Congress. Senate. Committee on the Judiciary. Dr. William J. Bennett to be Director of National Drug Control Policy: Report together with additional and minority views (to accompany the nomination ...). U.S. G.P.O., 1989.
Find full textUnited States. Congress. Senate. Committee on the Judiciary. Dr. William J. Bennett to be Director of National Drug Control Policy: Report together with additional and minority views (to accompany the nomination ...). U.S. G.P.O., 1989.
Find full textUnited Nations Dag Hammarskjold Library. Selective bibliography on drug abuse, drug traffic and drug control. the Library, 1990.
Find full textUnited States. Congress. Senate. Committee on the Judiciary. Confirmation hearing on the nomination of John P. Walters to be Director of the Office of National Drug Control Policy: Hearing before the Committee on the Judiciary, United States Senate, One Hundred Seventh Congress, first session, October 10, 2001. U.S. G.P.O., 2002.
Find full textUnited States. Congress. Senate. Committee on the Judiciary. Nomination of Barry R. McCaffrey to be Director of the National Drug Control Policy: Hearing before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session ... February 27, 1996. U.S. G.P.O., 1997.
Find full textUnited States. Congress. Senate. Committee on the Judiciary. Confirmation hearings of federal appointments to the Office of National Drug Control Policy (Bennett, Walton, and Morris): Hearings before the Committee on the Judiciary, United States Senate, One Hundred First Congress, first session, on the nominations of Dr. William J. Bennett to be Director ..., Reggie B. Walton to be Associate Director, and Stanley E. Morris to be Deputy Director ... March 1, 2, June 6, and September 20, 1989. U.S. G.P.O., 1991.
Find full textUnited States. Congress. Senate. Committee on the Judiciary. Confirmation hearings of federal appointments to the Office of National Drug Control Policy (Bennett, Walton, and Morris): Hearings before the Committee on the Judiciary, United States Senate, One Hundred First Congress, first session, on the nominations of Dr. William J. Bennett to be Director ..., Reggie B. Walton to be Associate Director, and Stanley E. Morris to be Deputy Director ... March 1, 2, June 6, and September 20, 1989. U.S. G.P.O., 1991.
Find full textUnited States. Congress. Senate. Committee on the Judiciary. Nomination of Lee Patrick Brown: Hearing before the Committee on the Judiciary, United States Senate, One Hundred Third Congress, first session, on the nomination of Lee Patrick Brown, to be Director of the Office of National Drug Control Policy, May 25, 1993. U.S. G.P.O., 1994.
Find full textUnited States. Congress. Senate. Committee on the Judiciary. Confirmation hearings of federal appointments to the Office of National Drug Control Policy (Bennett, Walton, and Morris): Hearings before the Committee on the Judiciary, United States Senate, One Hundred First Congress, first session ... March 1, 2, June 6, and September 20, 1989. U.S. G.P.O., 1991.
Find full textUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment. Senate confirmation of the FDA commissioner; and reauthorization of research activities by ADAMHA: Hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 3909 ... March 6, 1986. U.S. G.P.O., 1986.
Find full textBellera, Carolina L. Drug Target Selection and Validation. Springer International Publishing AG, 2023.
Find full textScotti, Marcus T., and Carolina Bellera. Drug Target Selection and Validation. Springer International Publishing AG, 2022.
Find full text